Nurse’s death linked to approved weight-loss drug
Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September. Her death certificate, seen by the BBC, lists multiple organ failure, septic shock and ...
Scots nurse’s death linked to weight-loss jab Mounjaro approved on NHS
The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,
Medpage Today on MSN2d
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 YearsSAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...
The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
For many patients on tirzepatide, a transformative medication used for weight loss and diabetes, the end of the drug's shortage was anything but welcome news. "I had an anxiety attack," said Maria ...
SAN ANTONIO – Once-weekly tirzepatide (Zepbound) reduced the risk for progression from prediabetes to type 2 diabetes (T2D) ...
US Weekly on MSN5d
Dog the Bounty Hunter’s Daughter Bonnie Chapman Says She Lost 58 Lbs With TirzepatideDuane "Dog the Bounty Hunter" Chapman and his late wife Beth Chapman’s daughter Bonnie Chapman is proud of her weight loss ...
Hosted on MSN10d
How to Get Tirzepatide (Zepbound) OnlineTirzepatide, sold under the brand names Zepbound and Mounjaro, is a prescription medication that works for weight loss by reducing appetite and increasing satiety. Administered as a once-weekly ...
Maggie O’Neill is a health writer and reporter based in New York who specializes in covering medical research and emerging wellness trends, with a focus on cancer and addiction. Prior to her ...
The death of a nurse has been linked to a weight loss jab due to be trialled by the UK government as a way of easing pressure on the overburdened state-run National Health Service, the BBC reported on ...
Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...
Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...
Hosted on MSN1d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?Removing the highly popular diabetes and obesity medications from the shortage list could limit options for patients who rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback